Table 2.
AGENT | MECHANISM OF ACTION | PRIMARY LIPID COMPONENT TARGET |
---|---|---|
Inclisiran (ALN-PCSsc) | siRNA to PCSK9 | LDL-C |
Bempedoic acid (ETC-1002) | Inhibition of ATP citrate lyase | LDL-C |
AKCEA-APO(a)-LRX | Antisense to apo(a) | Lp(a) |
AKCEA-APOCIII-LRX | Antisense to apoCIII | Triglycerides |
Evinacumab | Human monoclonal antibody to ANGPTL3 | Triglycerides and cholesterol |